nodes	percent_of_prediction	percent_of_DWPC	metapath
Temozolomide—CYP3A4—Vandetanib—thyroid cancer	0.124	0.508	CbGbCtD
Temozolomide—CYP3A4—Sorafenib—thyroid cancer	0.0746	0.306	CbGbCtD
Temozolomide—CYP3A4—Doxorubicin—thyroid cancer	0.0453	0.186	CbGbCtD
Temozolomide—Mental disability—Doxorubicin—thyroid cancer	0.000934	0.00124	CcSEcCtD
Temozolomide—Gastrointestinal pain—Sorafenib—thyroid cancer	0.000918	0.00121	CcSEcCtD
Temozolomide—Hot flush—Epirubicin—thyroid cancer	0.000903	0.00119	CcSEcCtD
Temozolomide—Thrombophlebitis—Doxorubicin—thyroid cancer	0.000903	0.00119	CcSEcCtD
Temozolomide—Blood alkaline phosphatase increased—Doxorubicin—thyroid cancer	0.000898	0.00119	CcSEcCtD
Temozolomide—Dermatitis exfoliative—Epirubicin—thyroid cancer	0.000895	0.00118	CcSEcCtD
Temozolomide—Menopausal symptoms—Epirubicin—thyroid cancer	0.000895	0.00118	CcSEcCtD
Temozolomide—Urticaria—Sorafenib—thyroid cancer	0.000892	0.00118	CcSEcCtD
Temozolomide—Abdominal pain—Sorafenib—thyroid cancer	0.000888	0.00117	CcSEcCtD
Temozolomide—Body temperature increased—Sorafenib—thyroid cancer	0.000888	0.00117	CcSEcCtD
Temozolomide—Purpura—Epirubicin—thyroid cancer	0.000876	0.00116	CcSEcCtD
Temozolomide—Vascular purpura—Doxorubicin—thyroid cancer	0.000874	0.00115	CcSEcCtD
Temozolomide—Hepatic failure—Doxorubicin—thyroid cancer	0.00087	0.00115	CcSEcCtD
Temozolomide—Eye pain—Doxorubicin—thyroid cancer	0.000866	0.00114	CcSEcCtD
Temozolomide—Diplopia—Epirubicin—thyroid cancer	0.000845	0.00112	CcSEcCtD
Temozolomide—Hot flush—Doxorubicin—thyroid cancer	0.000835	0.0011	CcSEcCtD
Temozolomide—Affect lability—Epirubicin—thyroid cancer	0.000831	0.0011	CcSEcCtD
Temozolomide—Dermatitis exfoliative—Doxorubicin—thyroid cancer	0.000828	0.00109	CcSEcCtD
Temozolomide—Menopausal symptoms—Doxorubicin—thyroid cancer	0.000828	0.00109	CcSEcCtD
Temozolomide—Hypersensitivity—Sorafenib—thyroid cancer	0.000827	0.00109	CcSEcCtD
Temozolomide—Face oedema—Epirubicin—thyroid cancer	0.000815	0.00108	CcSEcCtD
Temozolomide—Purpura—Doxorubicin—thyroid cancer	0.000811	0.00107	CcSEcCtD
Temozolomide—Asthenia—Sorafenib—thyroid cancer	0.000806	0.00107	CcSEcCtD
Temozolomide—Mood swings—Epirubicin—thyroid cancer	0.0008	0.00106	CcSEcCtD
Temozolomide—Pruritus—Sorafenib—thyroid cancer	0.000795	0.00105	CcSEcCtD
Temozolomide—Ataxia—Epirubicin—thyroid cancer	0.000794	0.00105	CcSEcCtD
Temozolomide—Dehydration—Epirubicin—thyroid cancer	0.000785	0.00104	CcSEcCtD
Temozolomide—Diplopia—Doxorubicin—thyroid cancer	0.000781	0.00103	CcSEcCtD
Temozolomide—Dry skin—Epirubicin—thyroid cancer	0.000774	0.00102	CcSEcCtD
Temozolomide—Affect lability—Doxorubicin—thyroid cancer	0.000769	0.00102	CcSEcCtD
Temozolomide—Hypokalaemia—Epirubicin—thyroid cancer	0.000769	0.00102	CcSEcCtD
Temozolomide—Diarrhoea—Sorafenib—thyroid cancer	0.000768	0.00102	CcSEcCtD
Temozolomide—Breast disorder—Epirubicin—thyroid cancer	0.000763	0.00101	CcSEcCtD
Temozolomide—Toxic epidermal necrolysis—Epirubicin—thyroid cancer	0.00076	0.00101	CcSEcCtD
Temozolomide—Aspartate aminotransferase increased—Epirubicin—thyroid cancer	0.00076	0.00101	CcSEcCtD
Temozolomide—Face oedema—Doxorubicin—thyroid cancer	0.000754	0.000997	CcSEcCtD
Temozolomide—Muscular weakness—Epirubicin—thyroid cancer	0.000745	0.000985	CcSEcCtD
Temozolomide—Alanine aminotransferase increased—Epirubicin—thyroid cancer	0.000745	0.000985	CcSEcCtD
Temozolomide—Dizziness—Sorafenib—thyroid cancer	0.000743	0.000982	CcSEcCtD
Temozolomide—Mood swings—Doxorubicin—thyroid cancer	0.00074	0.000979	CcSEcCtD
Temozolomide—Abdominal distension—Epirubicin—thyroid cancer	0.000735	0.000971	CcSEcCtD
Temozolomide—Ataxia—Doxorubicin—thyroid cancer	0.000735	0.000971	CcSEcCtD
Temozolomide—Dysphagia—Epirubicin—thyroid cancer	0.00073	0.000965	CcSEcCtD
Temozolomide—Dehydration—Doxorubicin—thyroid cancer	0.000727	0.000961	CcSEcCtD
Temozolomide—Dry skin—Doxorubicin—thyroid cancer	0.000716	0.000947	CcSEcCtD
Temozolomide—Vomiting—Sorafenib—thyroid cancer	0.000714	0.000944	CcSEcCtD
Temozolomide—Hypokalaemia—Doxorubicin—thyroid cancer	0.000711	0.00094	CcSEcCtD
Temozolomide—Rash—Sorafenib—thyroid cancer	0.000708	0.000936	CcSEcCtD
Temozolomide—Dermatitis—Sorafenib—thyroid cancer	0.000708	0.000935	CcSEcCtD
Temozolomide—Breast disorder—Doxorubicin—thyroid cancer	0.000706	0.000934	CcSEcCtD
Temozolomide—Toxic epidermal necrolysis—Doxorubicin—thyroid cancer	0.000704	0.00093	CcSEcCtD
Temozolomide—Aspartate aminotransferase increased—Doxorubicin—thyroid cancer	0.000704	0.00093	CcSEcCtD
Temozolomide—Headache—Sorafenib—thyroid cancer	0.000704	0.00093	CcSEcCtD
Temozolomide—Bronchitis—Epirubicin—thyroid cancer	0.000702	0.000928	CcSEcCtD
Temozolomide—Pancytopenia—Epirubicin—thyroid cancer	0.000693	0.000916	CcSEcCtD
Temozolomide—Alanine aminotransferase increased—Doxorubicin—thyroid cancer	0.000689	0.000911	CcSEcCtD
Temozolomide—Muscular weakness—Doxorubicin—thyroid cancer	0.000689	0.000911	CcSEcCtD
Temozolomide—Neutropenia—Epirubicin—thyroid cancer	0.000683	0.000902	CcSEcCtD
Temozolomide—Dysuria—Epirubicin—thyroid cancer	0.000683	0.000902	CcSEcCtD
Temozolomide—Abdominal distension—Doxorubicin—thyroid cancer	0.00068	0.000899	CcSEcCtD
Temozolomide—Upper respiratory tract infection—Epirubicin—thyroid cancer	0.000678	0.000897	CcSEcCtD
Temozolomide—Dysphagia—Doxorubicin—thyroid cancer	0.000675	0.000893	CcSEcCtD
Temozolomide—Pollakiuria—Epirubicin—thyroid cancer	0.000674	0.000891	CcSEcCtD
Temozolomide—Nausea—Sorafenib—thyroid cancer	0.000667	0.000882	CcSEcCtD
Temozolomide—Photosensitivity reaction—Epirubicin—thyroid cancer	0.000666	0.000881	CcSEcCtD
Temozolomide—Weight increased—Epirubicin—thyroid cancer	0.000664	0.000878	CcSEcCtD
Temozolomide—Weight decreased—Epirubicin—thyroid cancer	0.00066	0.000873	CcSEcCtD
Temozolomide—Hyperglycaemia—Epirubicin—thyroid cancer	0.000658	0.000871	CcSEcCtD
Temozolomide—Pneumonia—Epirubicin—thyroid cancer	0.000655	0.000865	CcSEcCtD
Temozolomide—Infestation NOS—Epirubicin—thyroid cancer	0.000651	0.00086	CcSEcCtD
Temozolomide—Infestation—Epirubicin—thyroid cancer	0.000651	0.00086	CcSEcCtD
Temozolomide—Bronchitis—Doxorubicin—thyroid cancer	0.00065	0.000859	CcSEcCtD
Temozolomide—Stevens-Johnson syndrome—Epirubicin—thyroid cancer	0.000645	0.000853	CcSEcCtD
Temozolomide—Pancytopenia—Doxorubicin—thyroid cancer	0.000641	0.000848	CcSEcCtD
Temozolomide—Neuropathy peripheral—Epirubicin—thyroid cancer	0.000638	0.000843	CcSEcCtD
Temozolomide—Stomatitis—Epirubicin—thyroid cancer	0.000634	0.000839	CcSEcCtD
Temozolomide—Urinary tract infection—Epirubicin—thyroid cancer	0.000633	0.000836	CcSEcCtD
Temozolomide—Dysuria—Doxorubicin—thyroid cancer	0.000632	0.000835	CcSEcCtD
Temozolomide—Neutropenia—Doxorubicin—thyroid cancer	0.000632	0.000835	CcSEcCtD
Temozolomide—Upper respiratory tract infection—Doxorubicin—thyroid cancer	0.000628	0.00083	CcSEcCtD
Temozolomide—Pollakiuria—Doxorubicin—thyroid cancer	0.000624	0.000825	CcSEcCtD
Temozolomide—Photosensitivity reaction—Doxorubicin—thyroid cancer	0.000616	0.000815	CcSEcCtD
Temozolomide—Hepatobiliary disease—Epirubicin—thyroid cancer	0.000616	0.000814	CcSEcCtD
Temozolomide—Weight increased—Doxorubicin—thyroid cancer	0.000615	0.000813	CcSEcCtD
Temozolomide—Weight decreased—Doxorubicin—thyroid cancer	0.000611	0.000808	CcSEcCtD
Temozolomide—Sinusitis—Epirubicin—thyroid cancer	0.000611	0.000807	CcSEcCtD
Temozolomide—Hyperglycaemia—Doxorubicin—thyroid cancer	0.000609	0.000805	CcSEcCtD
Temozolomide—Pneumonia—Doxorubicin—thyroid cancer	0.000606	0.000801	CcSEcCtD
Temozolomide—Infestation—Doxorubicin—thyroid cancer	0.000602	0.000796	CcSEcCtD
Temozolomide—Infestation NOS—Doxorubicin—thyroid cancer	0.000602	0.000796	CcSEcCtD
Temozolomide—Stevens-Johnson syndrome—Doxorubicin—thyroid cancer	0.000597	0.000789	CcSEcCtD
Temozolomide—Neuropathy peripheral—Doxorubicin—thyroid cancer	0.00059	0.00078	CcSEcCtD
Temozolomide—Haemoglobin—Epirubicin—thyroid cancer	0.000587	0.000776	CcSEcCtD
Temozolomide—Stomatitis—Doxorubicin—thyroid cancer	0.000587	0.000776	CcSEcCtD
Temozolomide—Urinary tract infection—Doxorubicin—thyroid cancer	0.000585	0.000774	CcSEcCtD
Temozolomide—Haemorrhage—Epirubicin—thyroid cancer	0.000584	0.000772	CcSEcCtD
Temozolomide—Hepatitis—Epirubicin—thyroid cancer	0.000584	0.000772	CcSEcCtD
Temozolomide—Hypoaesthesia—Epirubicin—thyroid cancer	0.000581	0.000769	CcSEcCtD
Temozolomide—Pharyngitis—Epirubicin—thyroid cancer	0.00058	0.000767	CcSEcCtD
Temozolomide—Urinary tract disorder—Epirubicin—thyroid cancer	0.000577	0.000763	CcSEcCtD
Temozolomide—Oedema peripheral—Epirubicin—thyroid cancer	0.000576	0.000761	CcSEcCtD
Temozolomide—Connective tissue disorder—Epirubicin—thyroid cancer	0.000574	0.000759	CcSEcCtD
Temozolomide—Urethral disorder—Epirubicin—thyroid cancer	0.000573	0.000757	CcSEcCtD
Temozolomide—Hepatobiliary disease—Doxorubicin—thyroid cancer	0.00057	0.000753	CcSEcCtD
Temozolomide—Sinusitis—Doxorubicin—thyroid cancer	0.000565	0.000747	CcSEcCtD
Temozolomide—Visual impairment—Epirubicin—thyroid cancer	0.000563	0.000744	CcSEcCtD
Temozolomide—Erythema multiforme—Epirubicin—thyroid cancer	0.000552	0.00073	CcSEcCtD
Temozolomide—Eye disorder—Epirubicin—thyroid cancer	0.000546	0.000722	CcSEcCtD
Temozolomide—Tinnitus—Epirubicin—thyroid cancer	0.000545	0.00072	CcSEcCtD
Temozolomide—Haemoglobin—Doxorubicin—thyroid cancer	0.000543	0.000718	CcSEcCtD
Temozolomide—Flushing—Epirubicin—thyroid cancer	0.000542	0.000717	CcSEcCtD
Temozolomide—Cardiac disorder—Epirubicin—thyroid cancer	0.000542	0.000717	CcSEcCtD
Temozolomide—Haemorrhage—Doxorubicin—thyroid cancer	0.000541	0.000715	CcSEcCtD
Temozolomide—Hepatitis—Doxorubicin—thyroid cancer	0.000541	0.000715	CcSEcCtD
Temozolomide—Hypoaesthesia—Doxorubicin—thyroid cancer	0.000538	0.000711	CcSEcCtD
Temozolomide—Pharyngitis—Doxorubicin—thyroid cancer	0.000537	0.000709	CcSEcCtD
Temozolomide—Urinary tract disorder—Doxorubicin—thyroid cancer	0.000534	0.000706	CcSEcCtD
Temozolomide—Oedema peripheral—Doxorubicin—thyroid cancer	0.000533	0.000704	CcSEcCtD
Temozolomide—Connective tissue disorder—Doxorubicin—thyroid cancer	0.000531	0.000702	CcSEcCtD
Temozolomide—Angiopathy—Epirubicin—thyroid cancer	0.00053	0.000701	CcSEcCtD
Temozolomide—Urethral disorder—Doxorubicin—thyroid cancer	0.00053	0.000701	CcSEcCtD
Temozolomide—Immune system disorder—Epirubicin—thyroid cancer	0.000528	0.000698	CcSEcCtD
Temozolomide—Mediastinal disorder—Epirubicin—thyroid cancer	0.000527	0.000696	CcSEcCtD
Temozolomide—Chills—Epirubicin—thyroid cancer	0.000524	0.000693	CcSEcCtD
Temozolomide—Visual impairment—Doxorubicin—thyroid cancer	0.000521	0.000689	CcSEcCtD
Temozolomide—Alopecia—Epirubicin—thyroid cancer	0.000516	0.000683	CcSEcCtD
Temozolomide—Mental disorder—Epirubicin—thyroid cancer	0.000512	0.000677	CcSEcCtD
Temozolomide—Erythema multiforme—Doxorubicin—thyroid cancer	0.000511	0.000676	CcSEcCtD
Temozolomide—Malnutrition—Epirubicin—thyroid cancer	0.000509	0.000672	CcSEcCtD
Temozolomide—Erythema—Epirubicin—thyroid cancer	0.000509	0.000672	CcSEcCtD
Temozolomide—Eye disorder—Doxorubicin—thyroid cancer	0.000505	0.000668	CcSEcCtD
Temozolomide—Tinnitus—Doxorubicin—thyroid cancer	0.000504	0.000666	CcSEcCtD
Temozolomide—Flushing—Doxorubicin—thyroid cancer	0.000502	0.000663	CcSEcCtD
Temozolomide—Cardiac disorder—Doxorubicin—thyroid cancer	0.000502	0.000663	CcSEcCtD
Temozolomide—Dysgeusia—Epirubicin—thyroid cancer	0.000498	0.000658	CcSEcCtD
Temozolomide—Back pain—Epirubicin—thyroid cancer	0.000492	0.00065	CcSEcCtD
Temozolomide—Angiopathy—Doxorubicin—thyroid cancer	0.00049	0.000648	CcSEcCtD
Temozolomide—Immune system disorder—Doxorubicin—thyroid cancer	0.000488	0.000646	CcSEcCtD
Temozolomide—Mediastinal disorder—Doxorubicin—thyroid cancer	0.000487	0.000644	CcSEcCtD
Temozolomide—Chills—Doxorubicin—thyroid cancer	0.000485	0.000641	CcSEcCtD
Temozolomide—Vision blurred—Epirubicin—thyroid cancer	0.000479	0.000634	CcSEcCtD
Temozolomide—Alopecia—Doxorubicin—thyroid cancer	0.000478	0.000632	CcSEcCtD
Temozolomide—Mental disorder—Doxorubicin—thyroid cancer	0.000474	0.000626	CcSEcCtD
Temozolomide—Ill-defined disorder—Epirubicin—thyroid cancer	0.000472	0.000624	CcSEcCtD
Temozolomide—Erythema—Doxorubicin—thyroid cancer	0.000471	0.000622	CcSEcCtD
Temozolomide—Malnutrition—Doxorubicin—thyroid cancer	0.000471	0.000622	CcSEcCtD
Temozolomide—Anaemia—Epirubicin—thyroid cancer	0.00047	0.000621	CcSEcCtD
Temozolomide—Agitation—Epirubicin—thyroid cancer	0.000467	0.000618	CcSEcCtD
Temozolomide—Dysgeusia—Doxorubicin—thyroid cancer	0.000461	0.000609	CcSEcCtD
Temozolomide—Malaise—Epirubicin—thyroid cancer	0.000459	0.000606	CcSEcCtD
Temozolomide—Vertigo—Epirubicin—thyroid cancer	0.000457	0.000604	CcSEcCtD
Temozolomide—Leukopenia—Epirubicin—thyroid cancer	0.000455	0.000602	CcSEcCtD
Temozolomide—Back pain—Doxorubicin—thyroid cancer	0.000455	0.000602	CcSEcCtD
Temozolomide—Palpitations—Epirubicin—thyroid cancer	0.000449	0.000594	CcSEcCtD
Temozolomide—Cough—Epirubicin—thyroid cancer	0.000444	0.000587	CcSEcCtD
Temozolomide—Vision blurred—Doxorubicin—thyroid cancer	0.000443	0.000586	CcSEcCtD
Temozolomide—Convulsion—Epirubicin—thyroid cancer	0.000441	0.000583	CcSEcCtD
Temozolomide—Hypertension—Epirubicin—thyroid cancer	0.000439	0.000581	CcSEcCtD
Temozolomide—Ill-defined disorder—Doxorubicin—thyroid cancer	0.000437	0.000577	CcSEcCtD
Temozolomide—Anaemia—Doxorubicin—thyroid cancer	0.000435	0.000575	CcSEcCtD
Temozolomide—Arthralgia—Epirubicin—thyroid cancer	0.000433	0.000572	CcSEcCtD
Temozolomide—Myalgia—Epirubicin—thyroid cancer	0.000433	0.000572	CcSEcCtD
Temozolomide—Agitation—Doxorubicin—thyroid cancer	0.000432	0.000572	CcSEcCtD
Temozolomide—Anxiety—Epirubicin—thyroid cancer	0.000431	0.00057	CcSEcCtD
Temozolomide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.00043	0.000569	CcSEcCtD
Temozolomide—Discomfort—Epirubicin—thyroid cancer	0.000428	0.000566	CcSEcCtD
Temozolomide—Malaise—Doxorubicin—thyroid cancer	0.000424	0.000561	CcSEcCtD
Temozolomide—Dry mouth—Epirubicin—thyroid cancer	0.000423	0.00056	CcSEcCtD
Temozolomide—Vertigo—Doxorubicin—thyroid cancer	0.000423	0.000559	CcSEcCtD
Temozolomide—Leukopenia—Doxorubicin—thyroid cancer	0.000421	0.000557	CcSEcCtD
Temozolomide—Confusional state—Epirubicin—thyroid cancer	0.000419	0.000553	CcSEcCtD
Temozolomide—Palpitations—Doxorubicin—thyroid cancer	0.000416	0.00055	CcSEcCtD
Temozolomide—Anaphylactic shock—Epirubicin—thyroid cancer	0.000415	0.000549	CcSEcCtD
Temozolomide—Oedema—Epirubicin—thyroid cancer	0.000415	0.000549	CcSEcCtD
Temozolomide—Infection—Epirubicin—thyroid cancer	0.000412	0.000545	CcSEcCtD
Temozolomide—Cough—Doxorubicin—thyroid cancer	0.000411	0.000543	CcSEcCtD
Temozolomide—Convulsion—Doxorubicin—thyroid cancer	0.000408	0.000539	CcSEcCtD
Temozolomide—Nervous system disorder—Epirubicin—thyroid cancer	0.000407	0.000538	CcSEcCtD
Temozolomide—Thrombocytopenia—Epirubicin—thyroid cancer	0.000406	0.000537	CcSEcCtD
Temozolomide—Hypertension—Doxorubicin—thyroid cancer	0.000406	0.000537	CcSEcCtD
Temozolomide—Skin disorder—Epirubicin—thyroid cancer	0.000403	0.000533	CcSEcCtD
Temozolomide—Hyperhidrosis—Epirubicin—thyroid cancer	0.000401	0.000531	CcSEcCtD
Temozolomide—Myalgia—Doxorubicin—thyroid cancer	0.000401	0.00053	CcSEcCtD
Temozolomide—Arthralgia—Doxorubicin—thyroid cancer	0.000401	0.00053	CcSEcCtD
Temozolomide—Anxiety—Doxorubicin—thyroid cancer	0.000399	0.000528	CcSEcCtD
Temozolomide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.000398	0.000526	CcSEcCtD
Temozolomide—Discomfort—Doxorubicin—thyroid cancer	0.000396	0.000523	CcSEcCtD
Temozolomide—Anorexia—Epirubicin—thyroid cancer	0.000396	0.000523	CcSEcCtD
Temozolomide—Dry mouth—Doxorubicin—thyroid cancer	0.000392	0.000518	CcSEcCtD
Temozolomide—Confusional state—Doxorubicin—thyroid cancer	0.000387	0.000512	CcSEcCtD
Temozolomide—Anaphylactic shock—Doxorubicin—thyroid cancer	0.000384	0.000508	CcSEcCtD
Temozolomide—Oedema—Doxorubicin—thyroid cancer	0.000384	0.000508	CcSEcCtD
Temozolomide—Infection—Doxorubicin—thyroid cancer	0.000382	0.000504	CcSEcCtD
Temozolomide—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000378	0.0005	CcSEcCtD
Temozolomide—Nervous system disorder—Doxorubicin—thyroid cancer	0.000377	0.000498	CcSEcCtD
Temozolomide—Thrombocytopenia—Doxorubicin—thyroid cancer	0.000376	0.000497	CcSEcCtD
Temozolomide—Insomnia—Epirubicin—thyroid cancer	0.000375	0.000496	CcSEcCtD
Temozolomide—Skin disorder—Doxorubicin—thyroid cancer	0.000373	0.000493	CcSEcCtD
Temozolomide—Paraesthesia—Epirubicin—thyroid cancer	0.000373	0.000493	CcSEcCtD
Temozolomide—Hyperhidrosis—Doxorubicin—thyroid cancer	0.000371	0.000491	CcSEcCtD
Temozolomide—Dyspnoea—Epirubicin—thyroid cancer	0.00037	0.000489	CcSEcCtD
Temozolomide—Somnolence—Epirubicin—thyroid cancer	0.000369	0.000488	CcSEcCtD
Temozolomide—Anorexia—Doxorubicin—thyroid cancer	0.000366	0.000484	CcSEcCtD
Temozolomide—Dyspepsia—Epirubicin—thyroid cancer	0.000365	0.000483	CcSEcCtD
Temozolomide—Decreased appetite—Epirubicin—thyroid cancer	0.000361	0.000477	CcSEcCtD
Temozolomide—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.000358	0.000474	CcSEcCtD
Temozolomide—Fatigue—Epirubicin—thyroid cancer	0.000358	0.000473	CcSEcCtD
Temozolomide—Pain—Epirubicin—thyroid cancer	0.000355	0.000469	CcSEcCtD
Temozolomide—Constipation—Epirubicin—thyroid cancer	0.000355	0.000469	CcSEcCtD
Temozolomide—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.00035	0.000463	CcSEcCtD
Temozolomide—Insomnia—Doxorubicin—thyroid cancer	0.000347	0.000459	CcSEcCtD
Temozolomide—Paraesthesia—Doxorubicin—thyroid cancer	0.000345	0.000456	CcSEcCtD
Temozolomide—Dyspnoea—Doxorubicin—thyroid cancer	0.000342	0.000453	CcSEcCtD
Temozolomide—Feeling abnormal—Epirubicin—thyroid cancer	0.000342	0.000452	CcSEcCtD
Temozolomide—Somnolence—Doxorubicin—thyroid cancer	0.000341	0.000451	CcSEcCtD
Temozolomide—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000339	0.000449	CcSEcCtD
Temozolomide—Dyspepsia—Doxorubicin—thyroid cancer	0.000338	0.000447	CcSEcCtD
Temozolomide—Decreased appetite—Doxorubicin—thyroid cancer	0.000334	0.000441	CcSEcCtD
Temozolomide—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000332	0.000438	CcSEcCtD
Temozolomide—Fatigue—Doxorubicin—thyroid cancer	0.000331	0.000438	CcSEcCtD
Temozolomide—Urticaria—Epirubicin—thyroid cancer	0.00033	0.000436	CcSEcCtD
Temozolomide—Pain—Doxorubicin—thyroid cancer	0.000328	0.000434	CcSEcCtD
Temozolomide—Constipation—Doxorubicin—thyroid cancer	0.000328	0.000434	CcSEcCtD
Temozolomide—Body temperature increased—Epirubicin—thyroid cancer	0.000328	0.000434	CcSEcCtD
Temozolomide—Abdominal pain—Epirubicin—thyroid cancer	0.000328	0.000434	CcSEcCtD
Temozolomide—Feeling abnormal—Doxorubicin—thyroid cancer	0.000316	0.000418	CcSEcCtD
Temozolomide—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000314	0.000415	CcSEcCtD
Temozolomide—Hypersensitivity—Epirubicin—thyroid cancer	0.000306	0.000404	CcSEcCtD
Temozolomide—Urticaria—Doxorubicin—thyroid cancer	0.000305	0.000403	CcSEcCtD
Temozolomide—Body temperature increased—Doxorubicin—thyroid cancer	0.000304	0.000401	CcSEcCtD
Temozolomide—Abdominal pain—Doxorubicin—thyroid cancer	0.000304	0.000401	CcSEcCtD
Temozolomide—Asthenia—Epirubicin—thyroid cancer	0.000298	0.000394	CcSEcCtD
Temozolomide—Pruritus—Epirubicin—thyroid cancer	0.000294	0.000388	CcSEcCtD
Temozolomide—Diarrhoea—Epirubicin—thyroid cancer	0.000284	0.000375	CcSEcCtD
Temozolomide—Hypersensitivity—Doxorubicin—thyroid cancer	0.000283	0.000374	CcSEcCtD
Temozolomide—Asthenia—Doxorubicin—thyroid cancer	0.000276	0.000364	CcSEcCtD
Temozolomide—Dizziness—Epirubicin—thyroid cancer	0.000274	0.000363	CcSEcCtD
Temozolomide—Pruritus—Doxorubicin—thyroid cancer	0.000272	0.000359	CcSEcCtD
Temozolomide—Vomiting—Epirubicin—thyroid cancer	0.000264	0.000349	CcSEcCtD
Temozolomide—Diarrhoea—Doxorubicin—thyroid cancer	0.000263	0.000347	CcSEcCtD
Temozolomide—Rash—Epirubicin—thyroid cancer	0.000262	0.000346	CcSEcCtD
Temozolomide—Dermatitis—Epirubicin—thyroid cancer	0.000261	0.000346	CcSEcCtD
Temozolomide—Headache—Epirubicin—thyroid cancer	0.00026	0.000344	CcSEcCtD
Temozolomide—Dizziness—Doxorubicin—thyroid cancer	0.000254	0.000336	CcSEcCtD
Temozolomide—Nausea—Epirubicin—thyroid cancer	0.000247	0.000326	CcSEcCtD
Temozolomide—Vomiting—Doxorubicin—thyroid cancer	0.000244	0.000323	CcSEcCtD
Temozolomide—Rash—Doxorubicin—thyroid cancer	0.000242	0.00032	CcSEcCtD
Temozolomide—Dermatitis—Doxorubicin—thyroid cancer	0.000242	0.00032	CcSEcCtD
Temozolomide—Headache—Doxorubicin—thyroid cancer	0.000241	0.000318	CcSEcCtD
Temozolomide—Nausea—Doxorubicin—thyroid cancer	0.000228	0.000302	CcSEcCtD
